Molecular genetics of Mycobacterium tuberculosis in relation to the discovery of novel drugs and vaccines

Tuberculosis

Volumn 84, Issue 1-2, 2004, Pages 63-75

  Kana, Bavesh D ^a   Mizrahi, Valerie ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

Gene knockout; Mycobacteriophage; Mycobacterium; Target validation; Transposon; Tuberculosis

Indexed keywords

BACTERIAL DNA; BCG VACCINE; PLASMID VECTOR;

BACTERIAL GENETICS; BACTERIAL GENOME; BACTERIAL METABOLISM; BACTERIAL STRAIN; BACTERIOPHAGE; BACTERIUM MUTANT; BCG VACCINATION; BREATHING; CONFERENCE PAPER; DNA REPAIR; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; GENETIC ANALYSIS; HEAT SENSITIVITY; HISTORY OF MEDICINE; INFECTION PREVENTION; KNOCKOUT GENE; MEDICAL INFORMATION; MOLECULAR CLONING; MOLECULAR GENETICS; MUTAGENESIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; REPORTER GENE; TRANSPOSON; TUBERCULOSIS; VALIDATION PROCESS;

EID: 0346461703     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2003.08.006     Document Type: Conference Paper

References (115)

1. Cole ST, Brosch R, Parkhill J, Garnier T, Churcher C, Harris D, Gordon SV, Eiglmeier K, Gas S, Barry III CE, Tekaia F, Badcock K, Basham D, Brown D, Chillingworth T, Connor R, Davies R, Devlin K, Feltwell T, Gentles S, Hamlin N, Holroyd S, Hornby T, Jagels K, Krogh A, McLean J, Moule S, Murphy L, Oliver K, Osborne J, Quail MA, Rajandream MA, Rogers J, Rutter S, Seeger K, Skelton J, Squares R, Squares S, Sulston JE, Taylor K, Whitehead S, Barrell BG. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998;393:537-44.
2. Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR, Wheeler PR, Honoré N, Garnier T, Churcher C, Harris D, Mungall K, Basham D, Brown D, Chillingworth T, Connor R, Davies RM, Devlin K, Duthoy S, Feltwell T, Fraser A, Hamlin N, Holroyd S, Hornsby T, Jagels K, Lacroix C, Maclean J, Moule S, Murphy L, Oliver K, Quail MA, Rajandream MA, Rutherford KM, Rutter S, Seeger K, Simon S, Simmonds M, Skelton J, Squares R, Squares S, Stevens K, Taylor K, Whitehead S, Woodward JR, Barrell BG. Massive gene decay in the leprosy bacillus. Nature 2001;409:1007-11.
3. Barry III CE, Wilson M, Lee R, Schoolnik GK. DNA microarrays and combinatorial chemical libraries: tools for the drug discovery pipeline. Int J Tuberc Lung Dis 2000;4(12 Suppl. 2):S189-93.
4. Duncan K, Sacchettini JC. Approaches to tuberculosis drug development. In: Hatfull GF, Jacobs WR, editors. Molecular genetics of mycobacteria. Washington, DC: ASM Press; 2000. p. 297-307.
5. McKinney JD, Honer zu Bentrup K, Munoz-Elias EJ, Miczak A, Chen B, Chan WT, Swenson D, Sacchettini JC, Jacobs Jr WR, Russell DG. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 2000;406:735-8.
6. Horwitz MA, Harth G, Dillon BJ, Maslesa-Galic S. Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. Proc Natl Acad Sci USA 2000;97:13853-8.
7. Hatfull GF, Jacobs Jr WR. Molecular genetics of mycobacteria. Washington DC: ASM Press; 2000.
8. Parish T, Stoker NG. In: Methods in molecular medicine, Mycobacterium tuberculosis protocols, vol. 54. Totowa, NJ: Humana Press; 2001.
9. Jacobs Jr WR. Mycobacterium tuberculosis: a once genetically intractable organism. In: Hatfull GF, Jacobs Jr WR, editors. Molecular genetics of mycobacteria. Washington, DC: ASM Press; 2000. p. 1-16.
10. Bloom BR, Mehra V, Young RA. Genes for the protein antigens of the tuberculosis and leprosy bacilli. Biosci Rep 1985;5:839-45.
11. Thole JE, Dauwerse HG, Das PK, Groothuis DG, Schouls LM, van Embden JD. Cloning of Mycobacterium bovis BCG DNA and expression of antigens in Escherichia coli. Infect Immun 1985;50:800-6.
12. Young RA, Bloom BR, Grosskinsky CM, Ivanyi J, Thomas D, Davis RW. Dissection of Mycobacterium tuberculosis antigens using recombinant DNA. Proc Natl Acad Sci USA 1985;82:2583-7.
13. Young RA, Mehra V, Sweetser D, Buchanan T, Clarke-Curtiss J, Davis RW, Bloom BR. Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae. Nature 1985;316:450-2.
14. Kieser T, Moss MT, Dale JW, Hopwood DA. Cloning and expression of Mycobacterium bovis BCG DNA in "Streptomyces lividans". J Bacteriol 1986;168:72-80.
15. Snapper SB, Melton RE, Mustafa S, Keiser T, Jacobs Jr WR. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol Microbiol 1990;4:1911-9.
16. Enserink M. Driving a stake into resurgent TB. Science 2001;293:234-5.
17. Potera C. New method churns out TB mutants. Science 1998;280:1350-1.
18. Young DB, Duncan K. Prospects for new interventions in the treatment and prevention of mycobacterial disease. Ann Rev Microbiol 1995;49:641-73.
19. Labidi A, David HL, Dussoix DR. Restriction endonuclease mapping and cloning of Mycobacterium fortuitum var. fortuitum plasmid pAL5000. Ann Inst Pasteur Microbiol 1985;136b:209-15.
20. Pashley C, Stoker NG. Plasmids in mycobacteria. In: Hatfull GF, Jacobs Jr WR, editors. Molecular genetics of mycobacteria. Washington, DC: ASM Press; 2000. p. 55-67.
21. Pelicic V, Jackson M, Reyrat JM, Jacobs Jr WR, Gicquel B, Guilhot C. Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1997;94:10955-60.
22. O'Gaora P, Barnini S, Hayward C, Filley E, Rook G, Young D, Thole J. Mycobacteria as immunogens: development of expression vectors for use in multiple mycobacterial species. Med Princ Pract 1997;6:91-6.
23. Guilhot C, Gicquel B, Martin C. Temperature-sensitive mutants of the Mycobacterium plasmid pAL5000. FEMS Microbiol Lett 1992;98:181-6.
24. Gavigan JA, Guilhot C, Gicquel B, Martin C. Use of conjugative and thermosensitive cloning vectors for transposon delivery to Mycobacterium smegmatis. FEMS Microbiol Lett 1995;127:35-9.
25. Jacobs Jr WR, Tuckman M, Bloom BR. Introduction of foreign DNA into mycobacteria using a shuttle plasmid. Nature 1987;327:532-5.
26. Derbyshire MK, Bardarov S. DNA transfer in Mycobacteria: conjugation and transduction. In: Hatfull GF, Jacobs Jr WR, editors. Molecular genetics of mycobacteria. Washington, DC: ASM Press; 2000. p. 93-107.
27. Hatfull GF. Molecular genetics of mycobacteriophages. In: Hatfull GF, Jacobs Jr WR, editors. Molecular genetics of mycobacteria. Washington, DC: ASM Press; 2000. p. 37-54.
28. Bardarov SS, Bardarov SS, Jacobs Jr WR. Transposon mutagenesis in mycobacteria using conditionally replicating mycobacteriophages. In: Parish T, Stoker NG, editors. Methods in molecular medicine, Mycobocterium tuberculosis protocols, vol. 54. Totowa, NJ: Humana Press; 2001. p. 43-57.
29. Glickman MS, Cox JS, Jacobs Jr WR. A novel mycolic acid cyclopropane synthetase is required for coding, persistence, and virulence of Mycobacterium tuberculosis. Mol Cell 2000;5:717-27.
30. Sirakova TD, Thirumala AK, Dubey VS, Sprecher H, Kolattukudy PE. The Mycobacterium tuberculosis pks2 gene encodes the synthase for the hepta-and octamethyl-branched fatty acids required for sulfolipid synthesis. J Biol Chem 2001;276:16833-9.
31. Lewis JA, Hatfull GF. Identification and characterization of the mycobacteriophage excisionase. Mol Microbiol 2000;35:350-60.
32. Cirillo JD, Barletta RG, Bloom BR, Jacobs Jr WR. A novel transposon trap for mycobacteria: isolation and characterization of IS1096. J Bacteriol 1991;173:7772-80.
33. McAdam RA, Weisbrod TR, Martin J, Scuderi JD, Brown AM, Cirillo JD, Bloom BR, Jacobs Jr WR. In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis. Infect Immun 1995;63:1004-12.
34. Camacho LR, Ensergueix D, Perez E, Gicquel B, Guilhot C. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis. Mol Microbiol 1999;34:257-67.
35. Cox JS, Chen B, McNeil M, Jacobs Jr WR. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice. Nature 1999;402:79-83.
36. McAdam RA, Quan S, Guilhot C. Mycobacterial transposons and their applications. In: Hatfull GF, Jacobs Jr WR, editors. Molecular genetics of mycobacteria. Washington, DC: ASM Press; 2000. p. 69-84.
37. Bardarov S, Kriakov J, Carriere C, Yu S, Vaamonde C, McAdam RA, Bloom BR, Hatfull GF, Jacobs Jr WR. Conditionally replicating bacteriophages: a system for transposon delivery Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1997;94:10961-6.
38. Machowski EE, McAdam RA, Derbyshire KM, Mizrahi V. Construction and application of mycobacterial reporter transposons. Gene 2000;25:67-75.
39. Hensel M, Shea JE, Gleeson C, Jones MD, Dalton E, Holden DW. Simultaneous identification of bacterial virulence genes by negative selection. Science 1995;269:400-3.
40. Glickman MS, Jacobs Jr WR. Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell 2001;104:477-85.
41. Camacho LR, Constant P, Raynaud C, Laneelle MA, Traccas JA, Gicquel B, Daffe M, Guilhot C. Analysis of the phthiocerol dimycoceroserate locus of Mycobacterium tuberculosis. Evidence that this lipid is involved in the cell wall permeability barrier. J Biol Chem 2001;276:19845-54.
42. Guilhot C, Otal I, van Rompaey I, Martin C, Gicquel B. Efficient transposition in mycobacteria: construction of Mycobacterium smegmatis insertional mutant libraries. J Bacteriol 1994;176:535-9.
43. Rubin EJ, Akerley BJ, Novik VN, Lampe DJ, Husson RN, Mekalanos JJ. In vivo transposition of mariner-based elements in enteric bacteria and mycobacteria. Proc Natl Acad Sci USA 1999;96:1645-50.
44. Griffin IV TJ, Parsons L, Leschziner AE, DeVost J, Derbyshire KM, Grindley ND. In vitro transposition of Tn522: a tool for DNA sequencing and mutagenesis. Nucl Acids Res 1999;27:3859-65.
45. Braunstein M, Griffin IV TJ, Kriakov JI, Friedman ST, Grindley ND, Jacobs Jr WR. Identification of genes encoding exported Mycobacterium tuberculosis proteins using a Tn522'phoA in vitro transposition system. J Bacteriol 2000;182:2732-40.
46. Husson RN, James BE, Young RA. Gene replacement and expression of foreign DNA in mycobacteria. J Bacteriol 1990;172:519-24.
47. Gordhan BG, Andersen SJ, De Meyer AR, Mizrahi V. Construction by homologous recombination and phenotypic characterization of a DNA polymerase domain polA mutant of Mycobocterium smegmatis. Gene 1996; 178:125-30.
48. +: a dominant selectable marker for gene replacement in mycobacteria. Mol Microbiol 1995;16:991-1000.
49. Aldovini A, Husson RN, Young RA. The uraA locus and homologous recombination in Mycobacterium bovis BCG. J Bacteriol 1993;175:7282-9.
50. Kalpana GV, Bloom BR, Jacobs Jr WR. Insertional mutagenesis and illegitimate recombination in mycobacteria. Proc Natl Acad Sci USA 1991;88:5433-7.
51. Reyrat M, Berthet FX, Gicquel B. The urease locus of Mycobacterium tuberculosis and its utilization for the demonstration of allelic exchange in Mycobacterium bovis bacillus Calmette-Guérin. Proc Natl Acad Sci USA 1995;92:8768-72.
52. Wilson T, Wards BJ, White SJ, Skou B, de Lisle GW, Collins DM. Production of avirulent Mycobacterium bovis strains by illegitimate recombination with deoxyribonucleic acid fragments containing an interrupted aphC gene. Tuberc Lung Dis 1997;78:229-35.
53. Balasubramanian V, Pavelka Jr MS, Bardarov SS, Martin J, Weisbrod TR, McAdam RA, Bloom BR, Jacobs Jr WR. Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates. J Bacteriol 1996;178:273-9.
54. Davis EO, Sedgwick SG, Colston MJ. Novel structure of the recA locus of Mycobacterium tuberculosis implies processing of the gene product. J Bacteriol 1991;173:5653-62.
55. McFadden J. Recombination in mycobacteria. Mol Microbiol 1996;21:205-11.
56. Azad AK, Sirakova TD, Rogers LM, Kolattukudy PE. Targeted replacement of the mycocerosic acid synthase gene in Mycobacterium bovis BCG produces a mutant that lacks mycosides. Proc Natl Acad Sci USA 1996;93:4787-92.
57. Marklund BI, Speert DP, Stokes RW. Gene replacement through homologous recombination in Mycobacterium intracellulare. J Bacteriol 1995;177:6100-5.
58. Baulard A, Kremer L, Locht C. Efficient homologous recombination in fast-growing and slow-growing mycobacteria. J Bacteriol 1996;178:3091-8.
59. Norman E, Dellagostin OA, McFadden J, Dale JW. Gene replacement by homologous recombination in Mycobacterium bovis BCG. Mol Microbiol 1995;16:755-60.
60. Frischkorn K, Sander P, Scholz M, Teschner K, Prammananan T, Böttger EC. Investigation of mycobacterial recA function: protein introns in the RecA of pathogenic mycobacteria do not affect competency for homologous recombination. Mol Microbiol 1998;29:1203-14.
61. Papavinasasundaram KG, Colston MJ, Davis EO. Construction and complementation of a recA deletion mutant of Mycobacterium smegmatis reveals that the intein in Mycobacterium tuberculosis recA does not affect RecA function. Mol Microbiol 1998;30:525-34.
62. Wards BJ, Collins DM. Electroporation at elevated temperatures substantially improves tranformation efficiency of slow-growing mycobacteria. FEMS Microbiol Lett 1996;145:101-5.
63. Reyrat JM, Pelicic V, Gicquel B, Rappuoli R. Counter-selectable markers: untapped tools for bacterial genetics and pathogenesis. Infect Immun 1998;66:4011-7.
64. Sander P, Springer B, Böttger EC. Gene replacement in Mycobacterium tuberculosis and Mycobacterium bovis BCG using rpsL+ as a dominant negative selectable marker. In: Parish T, Stoker NG, editors. Methods in molecular medicine, Mycobacterium tuberculosis protocols, vol. 54. Totowa, NJ: Humana Press; 2001. p. 93-104.
65. Jackson M, Camacho LR, Gicquel B, Guilhot C. Gene replacement and transposon delivery using the negative selection marker sacB. In: Parish T, Stoker NG, editors. Methods in molecular medicine, Mycobacterium tuberculosis protocols, vol. 54. Totowa, NJ: Humana Press; 2001. p. 59-75.
66. Pelicic V, Reyrat JM, Gicquel B. Generation of unmarked directed mutations in mycobacteria, using sucrose counter-selectable suicide vectors. Mol Microbiol 1996;20:919-25.
67. Berthet FX, Lagranderie M, Gounon P, Laurent-Winter C, Ensergueix D, Chavarot P, Thouron F, Maranghi E, Pelicic V, Portnoi D, Marchal G, Gicquel B. Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene. Science 1998;282:759-62.
68. Pavelka Jr MS, Jacobs Jr WR. Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis Bacillus Calmette-Guérin, and Mycobacterium tuberculosis H37Rv by allelic exchange. J Bacteriol 1999;181:4780-9.
69. Hinds J, Mahenthiralingamn E, Kempsell KE, Dunacan K, Stokes RW, Parish T, Stoker NG. Enhanced gene replacement in mycobacteria. Microbiology 1999;145:519-27.
70. Parish T, Gordhan BG, McAdam RA, Duncan K, Mizrahi V, Stoker NG. Production of mutants in amino acid biosynthetic genes of Mycobacterium tuberculosis by homologous recombination. Microbiology 1999;145:3497-503.
71. Gordhan BG, Parish T. Gene replacement using pretreated DNA. In: Parish T, Stoker NG, editors. Methods in molecular medicine, Mycobacterium tuberculosis protocols, vol. 54. Totowa, NJ: Humana Press; 2001. p. 77-92.
72. Parish T, Stoker NG. Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. Microbiology 2000;146:1969-75.
73. Boshoff HIM, Mizrahi V. Expression of Mycobacterium smegmatis pyrazinamidase in Mycobacterium tuberculosis confers hypersensitivity to pyrazinamide and related amides. J Bacteriol 2000;182:5479-85.
74. Primm TP, Andersen SJ, Mizrahi V, Avarbock D, Rubin H, Barry III CE. The stringent response of Mycobacterium tuberculosis is required for long-term survival. J Bacteriol 2000;182:4889-98.
75. Collins DM, Gicquel B. Genetics of mycobacterial virulence. In: Hatfull GF, Jacobs Jr WR, editors. Molecular genetics of mycobacteria. Washington, DC: ASM Press; 2000. p. 265-78.
76. Snewin V, Stewart G, Young D. Genetic strategies for vaccine development. In: Hatfull GF, Jacobs WR, editors. Molecular genetics of mycobacteria. Washington, DC: ASM Press; 2000. p. 279-96.
77. Guleria I, Teitelbaum R, McAdam RA, Kalpana G, Jacobs Jr WR, Bloom BR. Auxotrophic vaccines for tuberculosis. Nat Med 1996;2:334-7.
78. Jackson M, Phalen SW, Lagraderie M, Ensergueix D, Chavarot P, Marchal G, McMurray DN, Gicquel B, Guilhot C. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine. Infect Immun 1999;67:2867-73.
79. Smith DA, Parish T, Stoker NG, Bancroft GJ. Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates. Infect Immun 2001;69:1142-50.
80. Crawford RM, van der Verg L, Yuan L, Hadfield TL, Warren RL, Drazek ES, Houng HSH, Hammack C, Sasala K, Polsinelli T, Thompson J, Hoover DL. Deletion of purE attenuates Brucella melitensis in mice. Infect Immun 1996;64: 2188-92.
81. McFarland WC, Stocker BA. Effect of different purine auxotrophic mutations on mouse-virulence of a Vi-positive strain of Salmonella Dublin and of two strains of Salmonella typhimurium. Microb Pathog 1987;3:129-41.
82. Simmons CP, Hodgson AL, Strugnell RA. Attenuation and vaccine potential of aroQ mutants of Corynebacterium psuedotuberculosis. Infect Immun 1997;65:3048-56.
83. Bange FC, Brown AM, Jacobs Jr WR. Leucine auxotrophy restricts growth of Mycobacterium bovis BCG in macrophages. Infect Immun 1996;64:1794-9.
84. Hondalus MK, Bardarov S, Russell R, Chan J, Jacobs Jr WR, Bloom BR. Attenuation of and protection induced by a leucine auxotroph of Mycobacterium tuberculosis. Infect Immun 2000;68:2888-98.
85. Chambers MA, Williams A, Gavier-Widen D, Whelan A, Hall G, Marsh PD, Bloom BR, Jacobs WR, Hewinson RG. Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin. Infect Immun 2000; 68:7094-9.
86. Gomez JE, Bishai WR. whmD is an essential mycobacterial gene required for proper septation and cell division. Proc Natl Acad Sci USA 2000;97:8554-9.
87. Pavelka Jr MS, Jacobs Jr WR. Biosynthesis of diaminopimelate, the precursor of lysine and a component of peptidoglycan, is an essential function of Mycobacterium smegmatis. J Bacteriol 1996;178:6496-507.
88. Parish T, Stoker NG. glnE is an essential gene in Mycobacterium tuberculosis. J Bacteriol 2000;182: 5715-20.
89. Jordan A, Reichard P. Ribonucleotide reductases. Annu Rev Biochem 1998;67:71-98.
90. Yang F, Curran SC, Li LS, Avarbock D, Graf JD, Chua MM, Lu G, Salem J, Rubin H. Characterization of two genes encoding the Mycobacterium tuberculosis ribonucleotide reductase small subunit. J Bacteriol 1997;179:6408-15.
91. Dawes SS, Warner DF, Tsenova L, Timm J, McKinney JD, Kaplan G, Rubin H, Mizrahi V. Ribonucleotide reduction in Mycobacterium tuberculosis: Function and expression of genes encoding class Ib and class II ribonucleotide reductases. Infect Immun 2003; 71: In press.
92. Manabe YC, Saviola BJ, Sun L, Murphy JR, Bishai WR. Attenuation of virulence in Mycobacterium tuberculosis expressing a constitutively active iron repressor. Proc Natl Acad Sci USA 1999;96:12844-8.
93. Stewart GR, Snewin VA, Walzl G, Hussell T, Tormay P, O'Gaora P, Goyal M, Betts J, Brown IN, Young DB. Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection. Nat Med 2001;7:732-7.
94. Glickman MS, Cahill SM, Jacobs Jr WR. The Mycobacterium tuberculosis cmaA2 gene encodes a mycolic acid trans cyclopropane synthetase. J Biol Chem 2001;276:2228-33.
95. Cashel M, Gentry DR, Hernandez VJ, Vinella D. The stringent response. In: Neidhart FC, Curtis R, Ingraham JL, Lin ECC, Low KB, Magasanik B, Reznikoff WS, Riley M, Schaechter M, Umbarger HE, editors. Escherichia coli and Salmonella: cellular and molecular biology, vol. 1, 2nd ed. Washington, DC: ASM Press; 1996. p. 1488-96.
96. Avarbock DA, Salem J, Li LS, Wang ZM, Rubin H. Cloning and characterization of a bifunctional RelA/SpoT homologue from Mycobacterium tuberculosis. Gene 1999;233:261-9.
97. Wayne LG, Hayes LG. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of non-replicating persistence. Infect Immun 1996;64:2062-9.
98. Gentry D, Li T, Rosenberg M, McDevitt D. The rel gene is essential for in vitro growth of Staphylococcus aureus. J Bacteriol 2000;182:4995-7.
99. Cunningham AF, Spreadbury CL. Mycobacterial stationary phase induced by low oxygen tension: cell wall thickening and localization of the 16-kilodalton alpha-crystallin homolog. J Bacteriol 1998;180:801-8.
100. Sherman DR, Voskuil M, Schnappinger D, Liao R, Harrell MI, Schoolnik GK. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin. Proc Natl Acad Sci USA 2001;98:7534-9.
101. Wayne LG. In vitro model of hypoxically induced non-replicating persistence of Mycobacterium tuberculosis. In: Parish T, Stoker NG, editors. Methods in molecular medicine, Mycobacterium tuberculosis protocols, vol. 54. Totowa, NJ: Humana Press; 2001. p. 247-69.
102. Segal W. Growth dynamics of in vivo and in vitro grown mycobacterial pathogens. In: Kubica GP, Wayne LG, editors. The mycobacteria - a sourcebook. New York: Marcel Dekker; 1984. p. 547-73.
103. Poole RK, Cook GM. Redundancy of aerobic respiratory chains in bacteria? Routes, reasons and regulation. Adv Microb Physiol 2000;43:165-224.
104. Jünemann S. Cytochrome bd terminal oxidase. Biochim Biophys Acta 1997;1321:107-27.
105. Way SS, Sallustio S, Magliozzo RS, Goldberg MB. Impact of either elevated or decreased levels of cytochrome bd expression on Shigella flexneri virulence. J Bacteriol 1999;181:1229-37.
106. Dick T, Lee BH, Murugasu-Oei B. Oxygen depletion induced dormancy in Mycobacterium smegmatis. FEMS Microbiol Lett 1998;163:159-64.
107. Kana BD, Weinstein EA, Avarbock D, Dawes SS, Rubin H, Mizrahi V. Characterization of the cydAB-encoded cytochrome bd oxidase from Mycobacterium smegmatis. J Bacteriol 2001;183:7076-86.
108. Dawes SS, Rubin H, Mizrahi V. Unpublished results, 2003.
109. Mizrahi V, Andersen SJ. DNA repair in Mycobacterium tuberculosis. What have we learnt from the genome sequence? Mol Microbiol 1998;29:1331-9.
110. Nathan C, Shiloh MU. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc Natl Acad Sci USA 2000;97:8841-8.
111. Weber I, Fritz C, Ruttkowski S, Kreft A, Bange FC. Anaerobic nitrate reductase (narGHJI) activity of Mycobacterium bovis BCG in vitro and its contribution to virulence in immunodeficient mice. Mol Microbiol 2000;35:1017-25.
112. 6-alkylguanine-DNA alkyltransferase-deficient cells. Carcinogenesis 1997;18:1561-7.
113. Taverna P, Sedgwick B. Generation of an endogenous DNA-methylating agent by nitrosation in Escherichia coli. J Bacteriol 1996;178:5105-11.
114. Durbach SI, Springer B, Machowski EE, North RJ, Papavinasasundaram KG, Colston MJ, Böttger EC, Mizrahi V. DNA alkylation damage as a sensor of nitrosative stress in Mycobacterium tuberculosis. Infect Immun 2003;71: 997-1000.
115. Sander P, Papavinasasundaram KG, Dick T, Stavropolous E, Ellrot K, Springer B, Colston MJ, Böttger EC. Mycobacterium bovis BCG recA deletion mutant shows increased susceptibility to DNA-damaging agents but wild type survival in a mouse infection model. Infect Immun 2001;69:3562-8.